AU2003208037A1 - Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients - Google Patents
Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredientsInfo
- Publication number
- AU2003208037A1 AU2003208037A1 AU2003208037A AU2003208037A AU2003208037A1 AU 2003208037 A1 AU2003208037 A1 AU 2003208037A1 AU 2003208037 A AU2003208037 A AU 2003208037A AU 2003208037 A AU2003208037 A AU 2003208037A AU 2003208037 A1 AU2003208037 A1 AU 2003208037A1
- Authority
- AU
- Australia
- Prior art keywords
- nitroimidazole
- active ingredients
- anticancer agent
- topoisomerase inhibitor
- topoisomerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 239000003534 dna topoisomerase inhibitor Substances 0.000 title 1
- 229940044693 topoisomerase inhibitor Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020020007185A KR20030067275A (en) | 2002-02-07 | 2002-02-07 | Anticancer Agent Comprising Nitroimidazole and Topoisomerase Inhibitor as Active Ingredients |
| KR10-2002-0007185 | 2002-02-07 | ||
| PCT/KR2003/000276 WO2003066052A1 (en) | 2002-02-07 | 2003-02-07 | Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003208037A1 true AU2003208037A1 (en) | 2003-09-02 |
Family
ID=27725704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003208037A Abandoned AU2003208037A1 (en) | 2002-02-07 | 2003-02-07 | Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR20030067275A (en) |
| AU (1) | AU2003208037A1 (en) |
| WO (1) | WO2003066052A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200507752B (en) | 2003-03-28 | 2007-01-31 | Threshold Pharmaceuticals Inc | Compositions and methods for treating cancer |
| SI1896040T1 (en) | 2005-06-29 | 2012-12-31 | Threshold Pharmaceuticals, Inc. | Phosphoramidate alkylator prodrugs |
| ES2884044T3 (en) | 2006-12-26 | 2021-12-10 | Immunogenesis Inc | Phosphoramidate alkylating prodrug for cancer treatment |
| BRPI1003297A2 (en) * | 2010-07-07 | 2012-04-10 | Univ Minas Gerais | antineoplastic pharmaceutical compositions containing substituted nitroimidazole compounds |
| CN104546833A (en) * | 2015-02-09 | 2015-04-29 | 江苏澳格姆生物科技有限公司 | Application of ornidazole in preparation of medicines for inhibiting tumor cell metastasis and spread |
| EP3659307A4 (en) * | 2017-07-28 | 2021-09-22 | Yale University | ANTI-CANCER MEDICINAL PRODUCTS AND THEIR MANUFACTURING AND USE PROCEDURES |
-
2002
- 2002-02-07 KR KR1020020007185A patent/KR20030067275A/en not_active Withdrawn
-
2003
- 2003-02-07 AU AU2003208037A patent/AU2003208037A1/en not_active Abandoned
- 2003-02-07 WO PCT/KR2003/000276 patent/WO2003066052A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003066052A1 (en) | 2003-08-14 |
| KR20030067275A (en) | 2003-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002253619A1 (en) | Heterocyclic compound and antitumor agent containing the same active ingredients | |
| AU7490900A (en) | Chemical compounds and compositions and their use as cathepsin s inhibitors | |
| AU2003232851A1 (en) | Fungicidal combinations of active substances | |
| AU2002328494A1 (en) | Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients | |
| AU2002338806A1 (en) | Pharmaceutical combinations of pde-v inhibitors and other agents | |
| AU2002228317A1 (en) | Benz-1,3-azole derivatives and their uses as heparanase inhibitors | |
| EP1419785A4 (en) | Drugs containing chymase inhibitor and ace inhibitor as the active ingredients | |
| AU2003216579A1 (en) | Imidazole compounds as anti-inflammatory and analgesic agents | |
| AU2003232848A1 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
| AU2003220968A1 (en) | Anti-inflammatory agent | |
| AU2003277721A1 (en) | Beta-nitrostyrene compound and telomerase inhibitor having an anticancer activity | |
| AU2001286242A1 (en) | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | |
| AU2003226487A1 (en) | Formulation | |
| AU2001271266A1 (en) | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes | |
| AU2002230057A1 (en) | Diphenyl ether derivatives and their uses as heparanase inhibitors | |
| AU2003208037A1 (en) | Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients | |
| PT1646378E (en) | Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences | |
| AU2003227186A1 (en) | Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient | |
| AU2003258942A1 (en) | Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors | |
| AU2003303678A1 (en) | Urea derivatives and their use as anti-inflammatory agents | |
| AU2003289207A1 (en) | Anti-inflammatory agent | |
| AU2003206872A1 (en) | Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide | |
| AU2003259532A1 (en) | Ready-to-drink formulation containing an active ingredient | |
| AU2879801A (en) | Effervescent compositions comprising nimesulide | |
| AU2003245524A1 (en) | Cryosurgery compositions and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |